Circulatory nucleosome levels are significantly increased in early and late-onset preeclampsia

Prenatal Diagnosis

Volumn 25, Issue 8, 2005, Pages 700-703

  Zhong, Xiao Yan ^a   Gebhardt, Stefan ^b   Hillermann, Renate ^b   Tofa, Kashefa Carelse ^b   Holzgreve, Wolfgang ^a   Hahn, Sinuhe ^a  

^a UNIVERSITY WOMEN S HOSPITAL   (Switzerland)

^b STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

Circulatory nucleosomes; Preeclampsia

Indexed keywords

DNA;

ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FETUS WEIGHT; GESTATIONAL AGE; HUMAN; MATERNAL BLOOD; NUCLEOSOME; PATHOPHYSIOLOGY; PREECLAMPSIA; PREGNANCY COMPLICATION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR;

CASE-CONTROL STUDIES; COHORT STUDIES; DNA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GESTATIONAL AGE; HUMANS; NUCLEOSOMES; PRE-ECLAMPSIA; PREGNANCY; TIME FACTORS;

EID: 23844520949     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/pd.1204     Document Type: Article

References (17)

1. Chiu RW, Lo YM. 2004. The biology and diagnostic applications of fetal DNA and RNA in maternal plasma. Curr Top Dev Biol 61: 81-111.
2. Farina A, Sekizawa A, Sugito Y, et al. 2004. Fetal DNA in maternal plasma as a screening variable for preeclampsia. A preliminary nonparametric analysis of detection rate in low-risk nonsymptomatic patients. Prenat Diagn 24: 83-86.
3. Hahn S, Holzgreve W. 2002a. Fetal cells and cell-free fetal DNA in maternal blood: new insights into pre-eclampsia. Hum Reprod Update 8: 501-508.
4. Hahn S, Holzgreve W. 2002b. Prenatal diagnosis using fetal cells and cell-free fetal DNA in maternal blood: what is currently feasible? Clin Obstet Gynecol 45: 649-656.
5. Holdenrieder S, Stieber P. 2004a. Apoptotic markers in cancer. Clin Biochem 37: 605-617.
6. Holdenrieder S, Stieber P. 2004b. Therapy control in oncology by circulating nucleosomes. Ann N Y Acad Sci 1022: 211-216.
7. Holdenrieder S, Stieber P, Bodenmuller H, et al. 2001a. Circulating nucleosomes in serum. Ann N Y Acad Sci 945: 93-102.
8. Holdenrieder S, Stieber P, Bodenmuller H, et al. 2001b. Nucleosomes in serum as a marker for cell death. Clin Chem Lab Med 39: 596-605.
9. Holzgreve W, Hahn S. 1999. Novel molecular biological approaches for the diagnosis of preeclampsia. Clin Chem 45: 451-452.
10. Khorasanizadeh S. 2004. The nucleosome: from genomic organization to genomic regulation. Cell 116: 259-272.
11. Leung TN, Zhang J, Lau TK, Chan LY, Lo YM. 2001. Increased maternal plasma fetal DNA concentrations in women who eventually develop preeclampsia. Clin Chem 47: 137-139.
12. Levine RJ, Qian C, LeShane ES, et al. 2004. Two-stage elevation of cell-free fetal DNA in maternal sera before onset of preeclampsia. Am J Obstet Gynecol 190: 707-713.
13. Lo YM, Leung TN, Tein MS, et al. 1999. Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia. Clin Chem 45: 184-188.
14. Roberts JM, Redman CW. 1993. Pre-eclampsia: more than pregnancy-induced hypertension. Lancet 341: 1447-1451.
15. Swinkels DW, de Kok JB, Hendriks JC, Wiegerinck E, Zusterzeel PL, Steegers EA. 2002. Hemolysis, elevated liver enzymes, and low platelet count (HELLP) syndrome as a complication of preeclampsia in pregnant women increases the amount of cell-free fetal and maternal DNA in maternal plasma and serum. Clin Chem 48: 650-653.
16. Zhong XY, Holzgreve W, Hahn S. 2002. The levels of circulatory cell free fetal DNA in maternal plasma are elevated prior to the onset of preeclampsia. Hypertens Pregnancy 21: 77-83.
17. Zhong XY, Laivuori H, Livingston JC, et al. 2001. Elevation of both maternal and fetal extracellular circulating deoxyribonucleic acid concentrations in the plasma of pregnant women with preeclampsia. Am J Obstet Gynecol 184: 414-419.